Andrea Collins, MD
Hospitalist · Grenada, MSNPI 1093002743
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 27.2% of the total. Reporting peaked in 2023 at $149 and has fallen 72.5% since, to $41 in 2024. That places this record below the midpoint for hospitalist clinicians in MS, where the typical reported total is $523.
Across 21 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$122
- Novartis$112
- Novo Nordisk$34
- Bayer$28
- Global Blood Therapeutics, Inc.$28
- Sunovion Pharmaceuticals Inc.$27
- plus $97 from 5 others
What the payments were for
- Food & beverage$448100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 7 | $122 |
| Novartis | 2 | $112 |
| Novo Nordisk | 2 | $34 |
| Bayer | 2 | $28 |
| Global Blood Therapeutics, Inc. | 2 | $28 |
| Sunovion Pharmaceuticals Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $23 |
| Pfizer | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Merck | 1 | $12 |
How this compares
$448 in reported general payments places this provider in the 45th percentile of 102 hospitalist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperdal ConstaRisperidone Microspheres | 12 | $19,772 |
| XareltoRivaroxaban | 73 | $10,416 |
| JardianceEmpagliflozin | 40 | $7,024 |
| MyrbetriqMirabegron | 52 | $6,047 |
| AuryxiaFerric Citrate | 12 | $2,042 |
| Haloperidol | 151 | $1,570 |
| Haloperidol Decanoate | 12 | $1,146 |
| Divalproex Sodium | 123 | $1,145 |
| Bicalutamide | 53 | $861 |
| Atorvastatin Calcium | 121 | $845 |
| Spironolactone | 159 | $775 |
| Amlodipine Besylate | 197 | $747 |
| Ventolin HfaAlbuterol Sulfate | 11 | $694 |
| Potassium Chloride | 57 | $530 |
| Donepezil Hcl | 106 | $520 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Grenada
- Hamza LodhiSouthaven$164K
- Summer AllenGulfport$53K
- Stephen FarrowBiloxi$7K
- Kenneth BallJackson$3K
- Nathan BolesGulfport$3K
- Frederick AsherJackson$3K
- Bharat MalhotraJackson$3K
- Dasha CowartGulfport$2K
- Cherie PapizanHattiesburg$2K
- Volkan OzduranHattiesburg$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.